EUVIMEDEUVIMED entdecken
Open Access

Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer

Chaofan Liu, Xi Wang, Qinyu Li, Xintao Gao, Kai Zeng, Beining Li, Jianping Miao, Bolong Zheng, Jihong Liu, Zhihua Wang, Xianglin Yuan, Bo Liu

Theranostics · 21.04.2025 · 15 (12) · 5572-5591

DOI: 10.7150/thno.109994 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 21.04.2025. Verfasst von Chaofan Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China. Hauptthemen laut MEDLINE: Receptors, Androgen, Drug Resistance, Neoplasm, Apolipoproteins E, Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenDrug Resistance, NeoplasmApolipoproteins EProstatic NeoplasmsTripartite Motif ProteinsUbiquitin-Protein LigasesTranscription FactorsHumansMaleUbiquitinationCell Line, TumorImmunotherapySignal TransductionAnimalsMicePrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AR-targeted therapyApolipoprotein Eimmunotherapyprecision therapyprostate cancer

Substanzen

Receptors, AndrogenApolipoproteins EAR protein, humanTripartite Motif ProteinsUbiquitin-Protein LigasesTranscription FactorsApoE protein, human

Autor:innen und Institutionen

  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
  • Department of Urology, Sir RunRun Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
  • Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
  • Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • School of Computer Science and Technology, Huazhong University of Science and Technology, China.

Zitieren

APA

Liu, C., Wang, X., Li, Q., Gao, X., Zeng, K., Li, B., Miao, J., Zheng, B., Liu, J., Wang, Z., Yuan, X., & Liu, B. (2025). Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer. Theranostics, 15(12), 5572-5591. https://doi.org/10.7150/thno.109994

Vancouver

Liu C, Wang X, Li Q, Gao X, Zeng K, Li B, et al. Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer. Theranostics. 2025;15(12):5572-5591. doi:10.7150/thno.109994

BibTeX
@article{Liu2025,
  author = {Liu, Chaofan and Wang, Xi and Li, Qinyu and Gao, Xintao and Zeng, Kai and Li, Beining and Miao, Jianping and Zheng, Bolong and Liu, Jihong and Wang, Zhihua and Yuan, Xianglin and Liu, Bo},
  title = {Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {12},
  pages = {5572--5591},
  doi = {10.7150/thno.109994}
}
Kostenlos starten →